Hubei Jointown Pharmaceutical Co., Ltd. issued an announcement stating that the conversion price of the "jointly convertible bonds" will be adjusted from RMB 27.14/share to RMB 27.12/share, which will take effect on June 12, 2024. This adjustment is based on the profit distribution plan for 2023, with a cash dividend of RMB 0.16 for every 10 shares.
共同药业：“共同转债”转债转股价格调整
Guangdong Jointown Pharmaceutical Co., Ltd.: The conversion price of the jointly convertible bonds will be adjusted to debt-for-equity swaps.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.